Search Results - david+thomas

3 Results Sort By:
Novel HIV Antiviral Proteins and Their Uses in Therapeutic Methods
Unmet Need: HIV infection remains a significant global health burden despite availability of current antiviral treatments. With increasing drug resistance against available therapeutics, there is an urgent need for additional strategies to treat HIV. Technical Details: Researchers at Johns Hopkins University have identified novel candidates for HIV...
Published: 5/9/2024   |   Inventor(s): David Thomas, Ashwin Balagopal, Ramy El-Diwany, Robert Siliciano, Joel Blankson, Stuart Ray, Michael Chattergoon, Justin Bailey
Keywords(s): Biomarker, Disease Indication, HIV, HIV/AIDS, Infectious Diseases, Mechanism-of-action Biomarker, Therapeutic Matter, Therapeutics, Viral Infections
Category(s): Clinical and Disease Specializations, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Infectious Diseases > HIV/AIDS, Clinical and Disease Specializations > Infectious Diseases > Viral Infections
Mobile Health Support Intervention for Hepatitis C Linkage to Care and Hepatitis C Treatment Adherence Support
We have designed an e-health application that documents and supports community based hepatitis C linkage to care and treatment for patients diagnosed with hepatitis C (HCV). There are an estimated 3.2 million Americans in the United States infected with HCV. Only about 6% of individuals have been cured of their hepatitis C infections. The major prognosticator...
Published: 5/9/2024   |   Inventor(s): Oluwaseun Falade-Nwulia, David Thomas, Mark Sulkowski, Robert Bollinger, Alex Niculescu, Kathleen Page, Larry Chang, Jane Mckenzie-White, Maunank Shah
Keywords(s): Disease Indication, Disease Management System, Healthcare Management, Hepatitis C Virus, Hepatitis C Virus (HCV), Infectious Diseases, Operations Management, Viral Infections
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Infectious Diseases > Hepatitis C Virus, Clinical and Disease Specializations > Infectious Diseases > Viral Infections, Technology Classifications > Computers, Electronics & Software > Clinical Management, Technology Classifications > Computers, Electronics & Software > Healthcare IT, Technology Classifications > Computers, Electronics & Software, Clinical and Disease Specializations > Infectious Diseases
Use of Consensus Sequence as Vaccine Antigen to Enhance Recognition of Virulent Viral Variants
C04630: Use of Consensus Sequence as Vaccine Antigen to Enhance Recognition of Virulent Viral Variants Technical Details: Vaccines for diverse viruses will be most effective when they direct the recipient?s response to recognize the most virulent form of the organism. Scientists at JHU have found that circulating strains of hepatitis C virus (HCV)...
Published: 5/9/2024   |   Inventor(s): Andrea Lynn Cox, David Thomas, Stuart Ray
Keywords(s): Biologics, Disease Indication, Hepatitis C Virus, Hepatitis C Virus (HCV), Infectious Diseases, Therapeutic Matter, Therapeutic Substance, Therapeutics, Vaccine, Viral Infections
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Infectious Diseases > Hepatitis C Virus, Clinical and Disease Specializations > Infectious Diseases > Viral Infections, Technology Classifications > Research Tools > Nucleic Acids, Technology Classifications > Therapeutic Modalities > Vaccines, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Research Tools, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum